麻豆传媒

Gastroenterology >

Inflammatory Bowel Disease

News, opinions and meeting coverage in gastroenterology.

Chronic Opioid Use High Among IBD Patients

Patients at single clinic were more likely to obtain multiple scrips

Pearls From: David Rubin, MD

Expert discusses how to treat C. diff in IBD patients

Post-Colonoscopy Complications Higher in IBD Patients

Noninvasive testing modalities could benefit high-risk patients

App Improves Quality of Life in IBD Patients

Increases patient engagement, yields better health outcomes

IBD Patients Have More Anxiety Than Docs Think

Patients, docs on same page regarding pain

Alvimopan Speeds GI Recovery in IBD Patients

Significantly decreased length of stay, researchers reported at AIBD

ACG Hosts Annual Meeting with World Gastroenterology Organisation

Thousands gather in Orlando for latest GI news, trends

Extreme Exercise Tied to Gut Damage

More than 70% peak power output impacts gastric motility

Robotically Controlled Capsule Scope Passes Early Tests

Tethered capsule can perform complex intracolonic maneuvers automatically

DDW 2017: Diversity Will Be Meeting's Strength

Four-society meeting has plenty to offer across and among specialties

Gut-Selective Tx Shows Safety Superiority in IBD

Vedolizumab doesn't carry infection burden of TNF inhibitors

PSC in Kids: Rare but Relentless

Large international cohort offers new insight

Cimzia in New Moms Found Safe for Nursing Babies

Only trace quantities found in breast milk

Some Benefit With Entyvio for Arthritis in Crohn's

Trend seen for treating extraintestinal manifestations

No Benefit Seen for Probiotics in Ulcerative Colitis

Cochrane review showed similar relapse rates for mesalazine and probiotics

'Yes' to Routine Colonoscopies in IBD

Screening lowered colorectal cancer incidence and colon cancer mortality.

Type of Contrast May Mean More Comfortable CT

CHICAGO -- Patients who underwent abdominal or pelvic CT imaging with a low-osmolar contrast agent reported more discomfort during the exam than patients who received an iso-osmolar agent, researchers said here.

Estrogen a Culprit in Inflammatory Bowel Disease

SAN DIEGO -- Postmenopausal women who take hormone replacement therapy are at increased risk for developing ulcerative colitis, while younger women using oral contraceptives are more likely to develop Crohn's disease.

FDA Approves Natalizumab (Tysabri) for Crohn's Disease

ROCKVILLE, Md. -- The FDA today approved natalizumab (Tysabri), the star-crossed multiple sclerosis agent, for refractory moderate-to- severe Crohn's disease showing evidence of inflammation.

ACG: Weight Gain with Infliximab in Crohn's Disease Confirmed but Not Explained

PHILADELPHIA -- Unexplained weight gain in patients with Crohn's disease treated with infliximab remains a mystery, according to investigators in a small study reported here.

Tysabri (Natalizumab) Allowed Back to Market with Restrictions

ROCKVILLE, Md. — The FDA has cleared the way for Tysabri (natalizumab), the multiple sclerosis drug, to go back on the market but under a special restricted distribution program.

Some NSAIDS Safe in Ulcerative Colitis or Crohn's -- Sometimes

ROCHESTER, Minn. - Patients with quiescent ulcerative colitis or Crohn's disease can use some non-steroidal anti-inflammatory drugs safely, particularly selective cyclooxygenase inhibitors, at least some of the time, according to two studies.

IBD Patients Prone to Other Autoimmune or Inflammatory Disorders

PHILADELPHIA-Patients with the inflammatory bowel disorders ulcerative colitis and Crohn's disease are significantly more likely to suffer from other conditions with an inflammatory or autoimmune basis, said researchers in two separate studies.